Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction
NCT: NCT07638995 · RECRUITING
Brief Summary
The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pacemaker to a dual chamber leadless pacemaker system, and 3) to compare the battery longevity of the Aveir AR at two years with the battery longevity of subjects implanted with dual chamber leadless pacemakers in the Aveir DR i2i study.
Frequently Asked Questions
What is Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction?
Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction is a clinical trial registered under NCT07638995. Current status: RECRUITING.
What is the status of NCT07638995?
The current status of NCT07638995 (Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction) is: RECRUITING.
When did Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction start?
Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction started on 2026-05-18.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.